Oramed Pharmaceuticals
ORMP
$2.35
Share price
0.43%
Change (1 day)
-15.16%
Change (1 year)
Categories
Earnings for Oramed Pharmaceuticals (ORMP)
Earnings in 2023 (TTM): $3.05 M
According to Oramed Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $3.05 M. an increase over its 2022 earnings that were of -$36.63 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Oramed Pharmaceuticals from 2006 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | $3.05 M | -108.33% |
| 2022 | -$36.63 M | 39.17% |
| 2021 | -$26.32 M | 73.93% |
| 2020 | -$15.14 M | 18.53% |
| 2019 | -$12.77 M | -16.62% |
| 2018 | -$15.32 M | 38.32% |
| 2017 | -$11.07 M | 12.51% |
| 2016 | -$9.84 M | 25.01% |
| 2015 | -$7.87 M | 18.18% |
| 2014 | -$6.66 M | 39.72% |
| 2013 | -$4.77 M | 46.4% |
| 2012 | -$3.26 M | 128.32% |
| 2011 | -$1.43 M | -51.47% |
| 2010 | -$2.94 M | 35.21% |
| 2009 | -$2.18 M | |
| 2007 | -$3.42 M | 607.04% |
| 2006 | -$0.49 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $15.42 B | 505,781.97% | 🇩🇰 Denmark |
 Sanofi SNY | $8.39 B | 275,157.05% | 🇫🇷 France |
 Ultragenyx RARE | -$0.55 B | -17,885.57% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | -$0.18 B | -5,907.18% | 🇺🇸 USA |
 Compugen CGEN | -$9.79 M | -420.79% | 🇮🇱 Israel |